The relationship between vitamin D status and adrenal insufficiency in critically ill children

J Clin Endocrinol Metab. 2013 May;98(5):E877-81. doi: 10.1210/jc.2013-1126. Epub 2013 Apr 1.

Abstract

Context: Recent studies in critically ill populations have suggested both adrenal insufficiency (AI) and vitamin D deficiency to be associated with worse clinical outcome. There are multiple mechanisms through which these pleiotropic hormones might synergistically influence critical illness.

Objective: The aim of the study was to investigate potential relationships between vitamin D status, adrenal status, and cardiovascular dysfunction in critically ill children.

Design: We conducted a secondary analysis of data from a prospective cohort study.

Setting and patients: The study was conducted on 319 children admitted to 6 Canadian tertiary-care pediatric intensive care units.

Main outcome measures: Vitamin D status was determined through total 25-hydroxyvitamin D (25OHD) levels. AI was defined as a cortisol increment under 9 μg/dL after low-dose cosyntropin. Clinically significant cardiovascular dysfunction was defined as catecholamine requirement during pediatric intensive care unit admission.

Results: Using 3 different thresholds to define vitamin D deficiency, no association was found between vitamin D status and AI. Furthermore, linear regression failed to identify a relationship between 25OHD and baseline or post-cosyntropin cortisol. However, the association between AI and cardiovascular dysfunction was influenced by vitamin D status; compared to children with 25OHD above 30 nmol/L, AI in the vitamin D-deficient group was associated with significantly higher odds of catecholamine use (odds ratio, 5.29 vs 1.63; P = .046).

Conclusions: We did not find evidence of a direct association between vitamin D status and critical illness-related AI. However, our results do suggest that vitamin D deficiency exacerbates the effect of AI on cardiovascular stability in critically ill children.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 25-Hydroxyvitamin D 2 / blood
  • Adolescent
  • Adrenal Cortex / drug effects
  • Adrenal Cortex / metabolism
  • Adrenal Cortex / physiopathology*
  • Adrenal Insufficiency / complications*
  • Adrenal Insufficiency / diagnosis
  • Adrenal Insufficiency / physiopathology
  • Calcifediol / blood
  • Canada
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / physiopathology
  • Cardiovascular Diseases / therapy
  • Cardiovascular System / drug effects
  • Cardiovascular System / physiopathology*
  • Catecholamines / administration & dosage
  • Catecholamines / therapeutic use
  • Child
  • Child, Preschool
  • Cohort Studies
  • Cosyntropin
  • Hormones
  • Humans
  • Hydrocortisone / blood
  • Hydrocortisone / metabolism
  • Infant
  • Intensive Care Units, Pediatric
  • Nutritional Status*
  • Prospective Studies
  • Tertiary Care Centers
  • Vitamin D Deficiency / complications*
  • Vitamin D Deficiency / epidemiology
  • Vitamin D Deficiency / physiopathology

Substances

  • Catecholamines
  • Hormones
  • Cosyntropin
  • 25-Hydroxyvitamin D 2
  • Calcifediol
  • Hydrocortisone